N-Butyl-N-(4-hydroxybutyl)nitrosamine
CAS: 3817-11-6
Ref. 3D-FB177815
| 1g | Descatalogado | ||
| 2g | Descatalogado | ||
| 5g | Descatalogado | ||
| 10g | Descatalogado | ||
| 25g | Descatalogado |
Información del producto
Nombre:
N-Butyl-N-(4-hydroxybutyl)nitrosamine
Sinónimos:
- 1-Butanol, 4-(butylnitrosamino)-
- 1-Butanol, 4-(butylnitrosoamino)-
- 4-(Butylnitrosoamino)-1-butanol
- 4-Hydroxybutylbutylnitrosamine
- 4-[Butyl(Nitroso)Amino]Butan-1-Ol
- Butyl(4-hydroxybutyl)nitrosamine
- N-Butyl-N-(1-hydroxybutyl)nitrosamine
- N-Nitrosobutyl-4-hydroxybutylamine
- N-Nitrosobutylbutan-4-olamine
- N-n-Butyl-N-butan-4-ol-nitrosamine
- Ver más sinónimos
Descripción:
N-Butyl-N-(4-hydroxybutyl)nitrosamine (BBN) is a genotoxic carcinogen that causes urothelial carcinoma in laboratory animals. It is also a potential biomarker for bladder cancer in humans, based on the detection of BBN in maternal blood and urine. The pharmacological mechanism of BBN is not yet clear, but it may be due to its sodium salt or the presence of other genotoxic chemicals. A rat model has been developed for BBN toxicity studies. This drug inhibits protein synthesis by inhibiting RNA polymerase II and III, which are responsible for gene transcription and translation respectively.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
174.24 g/mol
Fórmula:
C8H18N2O2
Pureza:
90%Min
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
